These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9722757)

  • 1. Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (gamma-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels.
    Kurita Y; Terada H; Masuda H; Suzuki K; Fujita K
    Br J Urol; 1998 Aug; 82(2):224-30. PubMed ID: 9722757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer.
    Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K
    Int J Urol; 1996 Sep; 3(5):367-72. PubMed ID: 8886913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume and free-to-total PSA ratio: a prospective study.
    Moon DG; Yu JW; Lee JG; Kim JJ; Koh SK; Cheon J
    BJU Int; 2000 Oct; 86(6):670-4. PubMed ID: 11069374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition zone volume-adjusted prostate-specific antigen value predicts extracapsular carcinoma of the prostate in patients with intermediate prostate-specific antigen levels.
    Kurita Y; Suzuki A; Masuda H; Ushiyama T; Suzuki K; Fujita K
    Eur Urol; 1998; 33(1):32-8. PubMed ID: 9471039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    Int J Urol; 2005 Oct; 12(10):881-5. PubMed ID: 16323981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
    Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
    Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
    Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
    BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate.
    Kalish J; Cooner WH; Graham SD
    Urology; 1994 May; 43(5):601-6. PubMed ID: 7513104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer].
    Martínez Jabaloyas JM; García Morata F; Villamón Fort R; Pastor Hernández F; Gil Salom M; García Sisamón F
    Actas Urol Esp; 2003 Jun; 27(6):442-9. PubMed ID: 12918151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of measuring total PSA, PSA density, gamma-seminoprotein and gamma-seminoprotein/total PSA in prostate cancer prediction.
    Sasaki R; Habuchi T; Sato K; Akao T; Kakinuma H; Zhang LQ; Wang L; Matsuo S; Sasaki S; Ogawa O; Kato T
    Jpn J Clin Oncol; 2000 Aug; 30(8):337-42. PubMed ID: 11059338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume adjustment for intermediate prostate-specific antigen values in a screening population.
    Bangma CH; Grobbee DE; Schröder FH
    Eur J Cancer; 1995; 31A(1):12-4. PubMed ID: 7535074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
    Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
    Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.
    Dinçel C; Caşkurlu T; Taşçi AI; Cek M; Sevin G; Fazlioğlu A
    Int Urol Nephrol; 1999; 31(4):497-509. PubMed ID: 10668945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels.
    Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Wang XJ
    Int Urol Nephrol; 2012 Jun; 44(3):807-15. PubMed ID: 22311386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
    Kang SH; Bae JH; Park HS; Yoon DK; Moon DG; Kim JJ; Cheon J
    Int J Urol; 2006 Jul; 13(7):910-4. PubMed ID: 16882054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of prostate specific antigen (PSA) adjusted to transition zone in prostatic cancer detection].
    Jara Rascón J; Subirá Rios D; Lledó Garcia E; Martínez Salamanca JI; Moncada Iribarren I; Hernández Fernández C
    Actas Urol Esp; 2005 May; 29(5):485-92. PubMed ID: 16013794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.